Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$108.52 USD

108.52
2,721,363

+0.63 (0.58%)

Updated Oct 31, 2024 04:00 PM ET

After-Market: $108.52 0.00 (0.00%) 7:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Cardinal Health (CAH) Advances But Underperforms Market: Key Facts

The latest trading day saw Cardinal Health (CAH) settling at $112.80, representing a +0.92% change from its previous close.

Reasons to Retain Cardinal Health Stock in Your Portfolio Now

CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.

Greenville Center to Boost CAH Stock's at-Home Solution Business

Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.

Zacks Investment Ideas feature highlights: Cardinal Health, Taiwan Semiconductor and Altria

Zacks Investment Ideas feature highlights: Cardinal Health, Taiwan Semiconductor and Altria.

Derek Lewis headshot

3 Consistent Dividend Growers to Buy for Passive Income: TSM, MO, CAH

For those seeking companies with a consistent history of steady payouts, all three of these stocks fit the criteria. Who doesn't like payday?

Cardinal Health (CAH) to Open New Distribution Center in Ohio

Cardinal Health's (CAH) new center is set to integrate cutting-edge technology and automation, enhancing efficiency, storage capacity and quality of service.

Zacks Investment Ideas feature highlights: Walmart, Cardinal Health and Eli Lilly

Walmart, Cardinal Health and Eli Lilly have been highlighted in this Investment Ideas article.

Derek Lewis headshot

3 Companies Reporting Remarkable Results: WMT, LLY, CAH

All three companies posted robust results and upped their outlooks, a bullish pairing. Is it time to buy?

Company News for Aug 15, 2024

Companies in The News Are: CAH,UBS,EAT,ESLT

Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View

Cardinal Health's (CAH) fourth-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.

Here's What Key Metrics Tell Us About Cardinal (CAH) Q4 Earnings

Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Cardinal Health (CAH) Q4 Earnings and Revenues Top Estimates

Cardinal (CAH) delivered earnings and revenue surprises of 6.98% and 1.95%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Cardinal Health (CAH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now

Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.

What's in Store for Cardinal Health (CAH) in Q4 Earnings?

Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.

Seeking Clues to Cardinal (CAH) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.

The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates

The Joint (JYNT) delivered earnings and revenue surprises of -500% and 2.06%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to Know

Cardinal Health (CAH) closed at $99.52 in the latest trading session, marking a +1.18% move from the prior day.

Merit Medical (MMSI) Q2 Earnings and Revenues Beat Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 4.55% and 0.92%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) Rises But Trails Market: What Investors Should Know

Cardinal Health (CAH) reachead $100.83 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cardinal Health (CAH) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, Cardinal Health (CAH) closed at $96.71, indicating a +0.91% shift from the previous trading day.

Why the Market Dipped But Cardinal Health (CAH) Gained Today

In the closing of the recent trading day, Cardinal Health (CAH) stood at $95.84, denoting a +0.44% change from the preceding trading day.

Cardinal Health's (CAH) China Syringe Makers Face FDA Warnings

FDA investigations into Cardinal Health's (CAH) China-based syringe manufacturers, Jiangsu Shenli and Jiangsu Caina, reveal significant quality violations, prompting recalls and import alerts.